Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

Baxter International Inc.

BAX

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of Baxter International Inc.. A complete text table follows the diagram.

Baxter Runs a Broad Healthcare Products Platform

The filing supports a consolidated healthcare-products view.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0001628280-26-028962
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

Labels and displayed flow values are reported filing values or exact disclosed subtotals.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

The filing reports $2,701M net sales; no unsupported product allocation is added.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
Baxter International Inc. revenue	1	$2.7B	$2,701.0M reported quarterly revenue
Healthcare products and services	2	$2.7B	Reported net sales

Financial flows · Millions of USD
From	To	Value
Baxter International Inc. revenue	Healthcare products and services	$2.7B